Unovus Respicalm+ Syrup
Unovus Respicalm+ Syrup : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL24076052TC
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- MAPLEDEX PHARMA SDN. BHD.
- Manufacturer
- NUTRI-HOME PHARMACEUTICAL INDUSTRIES SDN. BHD.
- Registration period starting
- 2024-07-04
- Published validity end
- 2029-07-04
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Platycodon grandiflorum | Platycodon grandiflorum[100 mg,10 ml] | Not identified |
| Siraitia grosvenorii | Siraitia grosvenorii[100 mg,10 ml] | Not identified |
| Thymus vulgaris | Thymus vulgaris[95 mg,10 ml] | Not identified |
| Sambucus nigra | Sambucus nigra[50 mg,10 ml] | Not identified |
| Hedera helix | Hedera helix[35 mg,10 ml] | Not identified |
| Honey | Honey[150 mg,10 ml] | Miel |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Platycodon grandiflorum[100 mg,10 ml],Siraitia grosvenorii[100 mg,10 ml],Thymus vulgaris[95 mg,10 ml],Sambucus nigra[50 mg,10 ml],Hedera helix[35 mg,10 ml],Honey[150 mg,10 ml]
- Valid until
- 2029-07-04
- Registration date
- 2024-07-04
- Published description
- NATURAL PRODUCT
- Licence holder
- MAPLEDEX PHARMA SDN. BHD.
- Producer
- NUTRI-HOME PHARMACEUTICAL INDUSTRIES SDN. BHD.
- Published name
- Unovus Respicalm+ Syrup
- Published reference
- 2024040314541T
- Registration number
- MAL24076052TC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL24076052TC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Thymus vulgaris
Read the warning, when it applies and the studies cited
THYME - THYMUS VULGARIS - Buccal
Route of administration: Buccal (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Health Canada monograph dated 28 March 2025
THYME - THYMUS VULGARIS - Oral
Route of administration: Oral (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
Ask a healthcare practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant.
Health Canada monograph dated 26 June 2026
THYME - THYMUS VULGARIS - Topical
Route of administration: Topical (Mills and Bone 2005; Blumenthal et al. 2000)
Cautions and warnings
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Contraindications
Do not use on deep or puncture wounds, animal bites or serious burns.
- Sambucus nigra
Read the warning, when it applies and the studies cited
ELDER – SAMBUCUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.